APO Research
Talk to an analyst

APO RESEARCH · REPORT

Streptococcus Pneumoniae Polysaccharide Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Streptococcus Pneumoniae Polysaccharide Vaccine Industry Growth and Trends Forecast to 2032

29 December 2025108 pages

Choose your research edition.

Industry ResearchStreptococcus Pneumoniae Polysaccharide Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Streptococcus Pneumoniae Polysaccharide Vaccine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Streptococcus Pneumoniae Polysaccharide Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Streptococcus Pneumoniae Polysaccharide Vaccine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Streptococcus Pneumoniae Polysaccharide Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Streptococcus Pneumoniae Polysaccharide Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Streptococcus Pneumoniae Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Streptococcus Pneumoniae Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Streptococcus Pneumoniae Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Streptococcus Pneumoniae Polysaccharide Vaccine include Yuxi Watson Biotechnology Co., Ltd, Merck & Co.,Inc, Pfizer Inc, Chengdu Institute of Biological Products Co., Ltd, Beijing Minhai Biotechnology Co., Ltd, Beijing Kexing Biological Products Co., Ltd, Serum Institute of India Pvt. Ltd, Sanofi Pasteur and Glaxosmithkline Plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Streptococcus Pneumoniae Polysaccharide Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Streptococcus Pneumoniae Polysaccharide Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Streptococcus Pneumoniae Polysaccharide Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Streptococcus Pneumoniae Polysaccharide Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Streptococcus Pneumoniae Polysaccharide Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Streptococcus Pneumoniae Polysaccharide Vaccine Market by Company

Yuxi Watson Biotechnology Co., Ltd

Merck & Co.,Inc

Pfizer Inc

Chengdu Institute of Biological Products Co., Ltd

Beijing Minhai Biotechnology Co., Ltd

Beijing Kexing Biological Products Co., Ltd

Serum Institute of India Pvt. Ltd

Sanofi Pasteur

Glaxosmithkline Plc

China National Biotec Group

Astellas Pharma Inc

Streptococcus Pneumoniae Polysaccharide Vaccine Segment by Type

Single Dose Vial

Pre-Filled Syringe

Streptococcus Pneumoniae Polysaccharide Vaccine Segment by Application

Hospital

Clinic

Streptococcus Pneumoniae Polysaccharide Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Streptococcus Pneumoniae Polysaccharide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Streptococcus Pneumoniae Polysaccharide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Streptococcus Pneumoniae Polysaccharide Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Streptococcus Pneumoniae Polysaccharide Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Streptococcus Pneumoniae Polysaccharide Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Single Dose Vial Table 2. Major Company of Pre-Filled Syringe Table 3. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2026) & (K Units) Table 5. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Streptococcus Pneumoniae Polysaccharide Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2027-2032) & (K Units) Table 10. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Streptococcus Pneumoniae Polysaccharide Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2026) & (K Units) Table 15. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2026) & (K Units) Table 17. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Streptococcus Pneumoniae Polysaccharide Vaccine Industry Trends Table 25. Streptococcus Pneumoniae Polysaccharide Vaccine Industry Drivers Table 26. Streptococcus Pneumoniae Polysaccharide Vaccine Industry Opportunities and Challenges Table 27. Streptococcus Pneumoniae Polysaccharide Vaccine Industry Restraints Table 28. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Company (2021-2026) & (K Units) Table 31. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Share by Company (2021-2026) Table 32. Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Streptococcus Pneumoniae Polysaccharide Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Streptococcus Pneumoniae Polysaccharide Vaccine Major Company Production Sites and Headquarters Table 35. Global Streptococcus Pneumoniae Polysaccharide Vaccine Company, Product Type & Application Table 36. Global Streptococcus Pneumoniae Polysaccharide Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Streptococcus Pneumoniae Polysaccharide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region (2021-2026) & (K Units) Table 41. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Streptococcus Pneumoniae Polysaccharide Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2027-2032) & (K Units) Table 57. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Streptococcus Pneumoniae Polysaccharide Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2026) & (K Units) Table 62. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2026) & (K Units) Table 64. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Yuxi Watson Biotechnology Co., Ltd Company Information Table 72. Yuxi Watson Biotechnology Co., Ltd Business Overview Table 73. Yuxi Watson Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Yuxi Watson Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 75. Yuxi Watson Biotechnology Co., Ltd Recent Development Table 76. Merck & Co.,Inc Company Information Table 77. Merck & Co.,Inc Business Overview Table 78. Merck & Co.,Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Merck & Co.,Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 80. Merck & Co.,Inc Recent Development Table 81. Pfizer Inc Company Information Table 82. Pfizer Inc Business Overview Table 83. Pfizer Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Pfizer Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 85. Pfizer Inc Recent Development Table 86. Chengdu Institute of Biological Products Co., Ltd Company Information Table 87. Chengdu Institute of Biological Products Co., Ltd Business Overview Table 88. Chengdu Institute of Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Chengdu Institute of Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 90. Chengdu Institute of Biological Products Co., Ltd Recent Development Table 91. Beijing Minhai Biotechnology Co., Ltd Company Information Table 92. Beijing Minhai Biotechnology Co., Ltd Business Overview Table 93. Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 95. Beijing Minhai Biotechnology Co., Ltd Recent Development Table 96. Beijing Kexing Biological Products Co., Ltd Company Information Table 97. Beijing Kexing Biological Products Co., Ltd Business Overview Table 98. Beijing Kexing Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Beijing Kexing Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 100. Beijing Kexing Biological Products Co., Ltd Recent Development Table 101. Serum Institute of India Pvt. Ltd Company Information Table 102. Serum Institute of India Pvt. Ltd Business Overview Table 103. Serum Institute of India Pvt. Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Serum Institute of India Pvt. Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 105. Serum Institute of India Pvt. Ltd Recent Development Table 106. Sanofi Pasteur Company Information Table 107. Sanofi Pasteur Business Overview Table 108. Sanofi Pasteur Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Sanofi Pasteur Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 110. Sanofi Pasteur Recent Development Table 111. Glaxosmithkline Plc Company Information Table 112. Glaxosmithkline Plc Business Overview Table 113. Glaxosmithkline Plc Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Glaxosmithkline Plc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 115. Glaxosmithkline Plc Recent Development Table 116. China National Biotec Group Company Information Table 117. China National Biotec Group Business Overview Table 118. China National Biotec Group Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. China National Biotec Group Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 120. China National Biotec Group Recent Development Table 121. Astellas Pharma Inc Company Information Table 122. Astellas Pharma Inc Business Overview Table 123. Astellas Pharma Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Astellas Pharma Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio Table 125. Astellas Pharma Inc Recent Development Table 126. North America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 128. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 129. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 130. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. North America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Streptococcus Pneumoniae Polysaccharide Vaccine Market Share by Country (2021-2026) Table 134. North America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Streptococcus Pneumoniae Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 136. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 138. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 139. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 140. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Market Share by Country (2021-2026) Table 144. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 148. Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 150. Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Market Share by Country (2021-2026) Table 154. Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 156. Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 158. Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 159. Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 160. Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Market Share by Country (2021-2026) Table 164. Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2026) & (K Units) Table 168. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 170. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Market Share by Country (2021-2026) Table 174. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Streptococcus Pneumoniae Polysaccharide Vaccine Distributors List Table 179. Streptococcus Pneumoniae Polysaccharide Vaccine Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Streptococcus Pneumoniae Polysaccharide Vaccine Image Figure 2. Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales (2021-2032) & (K Units) Figure 5. Single Dose Vial Image Figure 6. Global Single Dose Vial Sales YoY Growth (2021-2032) & (K Units) Figure 7. Pre-Filled Syringe Image Figure 8. Global Pre-Filled Syringe Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Streptococcus Pneumoniae Polysaccharide Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Streptococcus Pneumoniae Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Streptococcus Pneumoniae Polysaccharide Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Streptococcus Pneumoniae Polysaccharide Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Single Dose Vial
  • Pre-Filled Syringe
Applications
  • Hospital
  • Clinic
Companies covered
  • Yuxi Watson Biotechnology Co., Ltd
  • Merck & Co.,Inc
  • Pfizer Inc
  • Chengdu Institute of Biological Products Co., Ltd
  • Beijing Minhai Biotechnology Co., Ltd
  • Beijing Kexing Biological Products Co., Ltd
  • Serum Institute of India Pvt. Ltd
  • Sanofi Pasteur
  • Glaxosmithkline Plc
  • China National Biotec Group
  • Astellas Pharma Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Streptococcus Pneumoniae Polysaccharide Vaccine Market by Type
  6. 1.3.1 Single Dose Vial
  7. 1.3.2 Pre-Filled Syringe
  8. 1.4 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Type
  9. 1.4.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Streptococcus Pneumoniae Polysaccharide Vaccine Industry Trends
  2. 2.2 Streptococcus Pneumoniae Polysaccharide Vaccine Industry Drivers
  3. 2.3 Streptococcus Pneumoniae Polysaccharide Vaccine Industry Opportunities and Challenges
  4. 2.4 Streptococcus Pneumoniae Polysaccharide Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Streptococcus Pneumoniae Polysaccharide Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Streptococcus Pneumoniae Polysaccharide Vaccine Price (2021-2026)
  4. 3.4 Global Streptococcus Pneumoniae Polysaccharide Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Streptococcus Pneumoniae Polysaccharide Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Streptococcus Pneumoniae Polysaccharide Vaccine Company, Product Type & Application
  7. 3.7 Global Streptococcus Pneumoniae Polysaccharide Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Streptococcus Pneumoniae Polysaccharide Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Streptococcus Pneumoniae Polysaccharide Vaccine Tier 1, Tier 2, and Tier 3
4 Streptococcus Pneumoniae Polysaccharide Vaccine Regional Status and Outlook
  1. 4.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Historic Market Size by Region
  3. 4.2.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Streptococcus Pneumoniae Polysaccharide Vaccine by Application
  1. 5.1 Streptococcus Pneumoniae Polysaccharide Vaccine Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Application
  5. 5.2.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yuxi Watson Biotechnology Co., Ltd
  2. 6.1.1 Yuxi Watson Biotechnology Co., Ltd Company Information
  3. 6.1.2 Yuxi Watson Biotechnology Co., Ltd Business Overview
  4. 6.1.3 Yuxi Watson Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yuxi Watson Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  6. 6.1.5 Yuxi Watson Biotechnology Co., Ltd Recent Developments
  7. 6.2 Merck & Co.,Inc
  8. 6.2.1 Merck & Co.,Inc Company Information
  9. 6.2.2 Merck & Co.,Inc Business Overview
  10. 6.2.3 Merck & Co.,Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck & Co.,Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  12. 6.2.5 Merck & Co.,Inc Recent Developments
  13. 6.3 Pfizer Inc
  14. 6.3.1 Pfizer Inc Company Information
  15. 6.3.2 Pfizer Inc Business Overview
  16. 6.3.3 Pfizer Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  18. 6.3.5 Pfizer Inc Recent Developments
  19. 6.4 Chengdu Institute of Biological Products Co., Ltd
  20. 6.4.1 Chengdu Institute of Biological Products Co., Ltd Company Information
  21. 6.4.2 Chengdu Institute of Biological Products Co., Ltd Business Overview
  22. 6.4.3 Chengdu Institute of Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Chengdu Institute of Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  24. 6.4.5 Chengdu Institute of Biological Products Co., Ltd Recent Developments
  25. 6.5 Beijing Minhai Biotechnology Co., Ltd
  26. 6.5.1 Beijing Minhai Biotechnology Co., Ltd Company Information
  27. 6.5.2 Beijing Minhai Biotechnology Co., Ltd Business Overview
  28. 6.5.3 Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  30. 6.5.5 Beijing Minhai Biotechnology Co., Ltd Recent Developments
  31. 6.6 Beijing Kexing Biological Products Co., Ltd
  32. 6.6.1 Beijing Kexing Biological Products Co., Ltd Company Information
  33. 6.6.2 Beijing Kexing Biological Products Co., Ltd Business Overview
  34. 6.6.3 Beijing Kexing Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Beijing Kexing Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  36. 6.6.5 Beijing Kexing Biological Products Co., Ltd Recent Developments
  37. 6.7 Serum Institute of India Pvt. Ltd
  38. 6.7.1 Serum Institute of India Pvt. Ltd Company Information
  39. 6.7.2 Serum Institute of India Pvt. Ltd Business Overview
  40. 6.7.3 Serum Institute of India Pvt. Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Serum Institute of India Pvt. Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  42. 6.7.5 Serum Institute of India Pvt. Ltd Recent Developments
  43. 6.8 Sanofi Pasteur
  44. 6.8.1 Sanofi Pasteur Company Information
  45. 6.8.2 Sanofi Pasteur Business Overview
  46. 6.8.3 Sanofi Pasteur Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sanofi Pasteur Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  48. 6.8.5 Sanofi Pasteur Recent Developments
  49. 6.9 Glaxosmithkline Plc
  50. 6.9.1 Glaxosmithkline Plc Company Information
  51. 6.9.2 Glaxosmithkline Plc Business Overview
  52. 6.9.3 Glaxosmithkline Plc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Glaxosmithkline Plc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  54. 6.9.5 Glaxosmithkline Plc Recent Developments
  55. 6.10 China National Biotec Group
  56. 6.10.1 China National Biotec Group Company Information
  57. 6.10.2 China National Biotec Group Business Overview
  58. 6.10.3 China National Biotec Group Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 China National Biotec Group Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  60. 6.10.5 China National Biotec Group Recent Developments
  61. 6.11 Astellas Pharma Inc
  62. 6.11.1 Astellas Pharma Inc Company Information
  63. 6.11.2 Astellas Pharma Inc Business Overview
  64. 6.11.3 Astellas Pharma Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Astellas Pharma Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
  66. 6.11.5 Astellas Pharma Inc Recent Developments
7 North America by Country
  1. 7.1 North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country
  2. 7.1.1 North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country
  6. 7.2.1 North America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country
  2. 8.1.1 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country
  6. 8.2.1 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country
  2. 10.1.1 South America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country
  6. 10.2.1 South America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Streptococcus Pneumoniae Polysaccharide Vaccine Value Chain Analysis
  2. 12.1.1 Streptococcus Pneumoniae Polysaccharide Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Streptococcus Pneumoniae Polysaccharide Vaccine Production Mode & Process
  7. 12.2 Streptococcus Pneumoniae Polysaccharide Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Streptococcus Pneumoniae Polysaccharide Vaccine Distributors
  10. 12.2.3 Streptococcus Pneumoniae Polysaccharide Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst